TipRanks
Advertisement
Advertisement
Xylo Bio CSO to Present Neurotherapeutics Research at Industry Conference
PremiumPrivate CompaniesXylo Bio CSO to Present Neurotherapeutics Research at Industry Conference
13d ago
Conference Engagement Highlights Xylo Bio’s Focus on Neuropsychiatric Drug Development
Premium
Private Companies
Conference Engagement Highlights Xylo Bio’s Focus on Neuropsychiatric Drug Development
20d ago
Xylo Bio Highlights Precision Neuroscience Roots in DREADD Technology
Premium
Private Companies
Xylo Bio Highlights Precision Neuroscience Roots in DREADD Technology
28d ago
Xylo Bio Focuses on Strategic Alignment and Industry Visibility in Latest Weekly Developments
PremiumPrivate CompaniesXylo Bio Focuses on Strategic Alignment and Industry Visibility in Latest Weekly Developments
1M ago
Xylo Bio CSO to Speak at Neuropsychiatric Drug Development Summit
Premium
Private Companies
Xylo Bio CSO to Speak at Neuropsychiatric Drug Development Summit
2M ago
Xylo Bio – Weekly Recap
Premium
Private Companies
Xylo Bio – Weekly Recap
2M ago
Xylo Bio Highlights Research Advancing Low-Cost Fluorescent Imaging Tools
PremiumPrivate CompaniesXylo Bio Highlights Research Advancing Low-Cost Fluorescent Imaging Tools
2M ago
Xylo Bio – Weekly Recap
Premium
Private Companies
Xylo Bio – Weekly Recap
3M ago
Neuron-Based Computing and AI Convergence Highlighted by Xylo Bio
Premium
Private Companies
Neuron-Based Computing and AI Convergence Highlighted by Xylo Bio
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100